TCR² Therapeutics
Wolfgang Schamel is a Professor and Chairman at Institute of Biology III (Molecular Immunology) and Centre for Biological Signaling Studies (BIOSS) at the University of Freiburg, Germany.
This person is not in the org chart
This person is not in any offices
TCR² Therapeutics
TCR² Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.